Skip to content
10-Q

Quarterly Report

ATYR PHARMA, INC. ATYR

0001193125-25-269587

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 97.99M sh
Shares Diluted Q3 2025 · Sep 30, 2025 97.15M sh
Shares Diluted Q3 2025 · Sep 30, 2025 91.29M sh
Shares Diluted Q3 2025 · Sep 30, 2024 75.8M sh
Shares Diluted Q3 2025 · Sep 30, 2024 71.42M sh
Capex Q3 2025 · Sep 30, 2025 $46K
Capex Q3 2025 · Sep 30, 2024 $40K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$49.79M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$55.99M
Short Term Investments Q3 2025 · Sep 30, 2025 $79M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $6.15M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $11.06M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $11.46M
Stockholders Equity Q3 2025 · Sep 30, 2025 $80.24M
Stockholders Equity Q3 2025 · Dec 31, 2024 $70.02M
Current Liabilities Q3 2025 · Sep 30, 2025 $15.68M
Current Liabilities Q3 2025 · Dec 31, 2024 $14.97M
Current Assets Q3 2025 · Sep 30, 2025 $93.01M
Current Assets Q3 2025 · Dec 31, 2024 $81.95M
Total Assets Q3 2025 · Sep 30, 2025 $106.65M
Total Assets Q3 2025 · Dec 31, 2024 $96.83M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.26
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.66
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.23
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.69
Eps Basic Q3 2025 · Sep 30, 2025 −$0.26
Eps Basic Q3 2025 · Sep 30, 2025 −$0.66
Eps Basic Q3 2025 · Sep 30, 2024 −$0.23
Eps Basic Q3 2025 · Sep 30, 2024 −$0.69
Sga Expense Q3 2025 · Sep 30, 2025 $4.81M
Sga Expense Q3 2025 · Sep 30, 2025 $13.69M
Sga Expense Q3 2025 · Sep 30, 2024 $3.34M
Sga Expense Q3 2025 · Sep 30, 2024 $10.19M
Rd Expense Q3 2025 · Sep 30, 2025 $22.13M
Rd Expense Q3 2025 · Sep 30, 2025 $49.33M
Rd Expense Q3 2025 · Sep 30, 2024 $14.81M
Rd Expense Q3 2025 · Sep 30, 2024 $42.14M
Net Income Q3 2025 · Sep 30, 2025 −$25.74M
Net Income Q3 2025 · Sep 30, 2025 −$60.16M
Net Income Q3 2025 · Sep 30, 2024 −$17.26M
Net Income Q3 2025 · Sep 30, 2024 −$49.06M
Operating Income Q3 2025 · Sep 30, 2025 −$26.75M
Operating Income Q3 2025 · Sep 30, 2025 −$62.83M
Operating Income Q3 2025 · Sep 30, 2024 −$18.14M
Operating Income Q3 2025 · Sep 30, 2024 −$52.09M
Revenue Q3 2025 · Sep 30, 2025 $190K
Revenue Q3 2025 · Sep 30, 2025 $190K
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $235K